Mirae Asset Global Investments Co. Ltd. Grows Position in Henry Schein, Inc. (NASDAQ:HSIC)

Mirae Asset Global Investments Co. Ltd. increased its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 29.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,854 shares of the company's stock after buying an additional 3,650 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Henry Schein were worth $1,113,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Cromwell Holdings LLC lifted its position in Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after purchasing an additional 170 shares during the last quarter. Versant Capital Management Inc lifted its position in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after purchasing an additional 335 shares during the last quarter. City State Bank bought a new stake in Henry Schein in the fourth quarter valued at approximately $55,000. Farther Finance Advisors LLC lifted its position in Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock valued at $68,000 after purchasing an additional 346 shares during the last quarter. Finally, Mather Group LLC. lifted its position in Henry Schein by 43.7% in the fourth quarter. Mather Group LLC. now owns 1,503 shares of the company's stock valued at $104,000 after purchasing an additional 457 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Henry Schein Stock Down 2.1 %

Shares of NASDAQ HSIC traded down $1.62 during trading on Friday, reaching $76.00. The company had a trading volume of 1,455,207 shares, compared to its average volume of 1,474,978. The stock has a market cap of $9.48 billion, a PE ratio of 31.28, a P/E/G ratio of 2.21 and a beta of 0.91. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The business's 50-day moving average is $74.01 and its 200 day moving average is $72.00.

Insider Activity

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company's stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.14% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Jefferies Financial Group boosted their target price on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Wells Fargo & Company assumed coverage on Henry Schein in a research note on Friday. They set an "equal weight" rating and a $80.00 target price on the stock. Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price target on the stock. Finally, Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and upped their price target for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Eight equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Henry Schein currently has a consensus rating of "Moderate Buy" and an average target price of $80.09.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.